NCT01853540View on ClinicalTrials.gov

Sildenafil for PNTM Infection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Nontuberculous Mycobacterial Infection
Interventions
DRUG

Sildenafil

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01853540 - Sildenafil for PNTM Infection | Biotech Hunter | Biotech Hunter